BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home » Authors » Kim Coghill

Articles by Kim Coghill

House, Senate Pass Bioterrorism Bill On To Bush For Signature

May 28, 2002
By Kim Coghill

FDA Panel Votes In Favor Of Biogen's Amevive For Psoriasis

May 24, 2002
By Kim Coghill
SILVER SPRING, Md. - A panel of experts advising the FDA recommended approval of Biogen Inc.'s psoriasis drug Amevive on Thursday. (BioWorld Today)
Read More

FDA Panel Votes In Favor Of Biogen's Amevive For Psoriasis

May 24, 2002
By Kim Coghill
SILVER SPRING, Md. - A panel of experts advising the FDA recommended approval of Biogen Inc.'s psoriasis drug Amevive on Thursday. (BioWorld Today)
Read More

BIO Holds First Meeting On Biotechnology And The Law

May 22, 2002
By Kim Coghill

BIO Holds First Meeting On Biotechnology And The Law

May 22, 2002
By Kim Coghill

PDL Drops Development Of Zamyl After Phase III Failure

May 21, 2002
By Kim Coghill
Protein Design Labs Inc. decided against further development of Zamyl as an acute myeloid leukemia treatment on news that its Phase III trial failed to show statistical significance. (BioWorld Today)
Read More

PDL Drops Development Of Zamyl After Phase III Failure

May 21, 2002
By Kim Coghill
Protein Design Labs Inc. decided against further development of Zamyl as an acute myeloid leukemia treatment on news that its Phase III trial failed to show statistical significance. (BioWorld Today)
Read More

Variagenics Trims Staff, Programs To Focus On Cancer Diagnostics

May 20, 2002
By Kim Coghill

Variagenics Trims Staff, Programs To Focus On Cancer Diagnostics

May 20, 2002
By Kim Coghill

Manufacturing Snag Could Set NPS Back On Osteoporosis Drug

May 17, 2002
By Kim Coghill
Previous 1 2 … 119 120 121 122 123 124 125 126 127 … 142 143 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 26, 2026.
  • MRI image brain on black background

    ADPD 2026: Can we prevent dementia? Scientists quantify it

    BioWorld
    Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
  • Illustration of Alzheimer's disease in the brain

    ADPD 2026: Three inflection points to target Alzheimer’s disease

    BioWorld Science
    A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
  • Art concept for Parkinson's disease

    Emerging therapeutic strategies for Parkinson’s at ADPD 2026

    BioWorld
    Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 24, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing